Stoke Therapeutics Stock: Dravet Data Sends Shares Soaring One For Watchlist (NASDAQ:STOK) | Old North State Wealth News
Connect with us

Investing

Stoke Therapeutics Stock: Dravet Data Sends Shares Soaring One For Watchlist (NASDAQ:STOK)

Published

on

tadamichi

Investment Overview

Stoke Therapeutics’ (NASDAQ:STOK) stock has been soaring in response to the positive data the company shared from two open-label Phase 1/2a studies and two open-label extension (“OLE”) studies of its lead drug candidate STK-001 in children and

Read the full article here

Trending

Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.